Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.

Cite this paper

@article{Cornillie2001InfliximabIP, title={Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.}, author={Freddy J Cornillie and David Shealy and G R D'haens and Karel Geboes and Gert A Van Assche and J. L. Ceuppens and Claudia Wagner and Thomas F. Schaible and Scott Eric Plevy and Stephan Raoul Targan and Paul J. Rutgeerts}, journal={Alimentary pharmacology & therapeutics}, year={2001}, volume={15 4}, pages={463-73} }